Republican Senator Susan Collins of Maine, who is frequently considered the “swing” Senator among the most likely to side with Democrat now has the dubious distinction of being the most unpopular Senator in the country.
TheHill reports Sen. Susan Collins (R-Maine), who has come under mounting pressure as President Trump’s impeachment trial starts, is now the Senate’s most unpopular member, displacing Senate Majority Leader Mitch McConnell (R-Ky.) in the rankings, according to a new tracking poll.
A quarterly Morning Consult tracking poll finds that Collins’s net approval rating has dropped 10 points in her state since the end of September, a sign of the intense fire she has taken from critics since the House launched its impeachment inquiry.
Morning Consult reported Thursday evening in a preview of its survey findings that Collins, who is up for reelection this year, now registers a 52 percent disapproval. Her approval rating stood at 42 percent.
McConnell, the second least popular senator, registered a disapproval rating of 50 percent and an approval rating of 37 percent among the voters in his state of Kentucky.
Collins is considered a key swing vote and her vote has implications beyond her own.
Collins’s no vote resulted in the failure of the skinny repeal of Obamacare.
Her “yes” vote on Kavanaugh likely allowed him to be confirmed and was reoirted to influence the votes of others including Senator Joe Manchin.
Mitt Romney has also made it known he would like to hear from John Bolton.
TheHill reports Sen. Susan Collins (R-Maine) said on Thursday that it’s “likely” she would support calling witnesses after the initial phase of the impeachment trial but has not yet made a decision on any particular individual.
“While I need to hear the case argued and the questions answered, I tend to believe having additional information would be helpful. It is likely that I would support a motion to call witnesses at that point in the trial just as I did in 1999,” Collins said in a statement, referring to the Clinton impeachment trial.